Lantern Pharma Inc.
LTRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001763950
No open-market purchases or sales by Lantern Pharma Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $12.0M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Lantern Pharma Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +4 vs. Q1 2023
- Shares held
- 1.15M
- +68.4K (+6.3%) vs. Q1 2023
- Total value
- $6.50M
- +$1.26M (+24.1%) vs. Q1 2023
- New holders
- 5
- 7 more added
- Sold out
- 1
- 7 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LTRN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 39 | $12.0M |
| Q1 2026 | 33 | $2.87M |
| Q4 2025 | 33 | $6.91M |
| Q3 2025 | 30 | $9.89M |
| Q2 2025 | 35 | $7.11M |
| Q1 2025 | 32 | $8.62M |
| Q4 2024 | 32 | $8.00M |
| Q3 2024 | 31 | $4.90M |
| Q2 2024 | 39 | $6.01M |
| Q1 2024 | 34 | $9.75M |
| Q4 2023 | 30 | $4.94M |
| Q3 2023 | 27 | $3.93M |
| Q2 2023 | 25 | $6.50M |
| Q1 2023 | 21 | $5.23M |
| Q4 2022 | 23 | $5.40M |
| Q3 2022 | 26 | $6.84M |
| Q2 2022 | 26 | $8.06M |
| Q1 2022 | 25 | $10.4M |
| Q4 2021 | 33 | $13.1M |
| Q3 2021 | 25 | $15.7M |
| Q2 2021 | 22 | $19.7M |
| Q1 2021 | 24 | $25.5M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Lantern Pharma Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 367,454 | $2.07M | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 171,465 | $967.1K | 0.01% | −650−0.4% | Reduced |
| Carlson Capital L P | 95,000 | $535.8K | 0.05% | −29,900−23.9% | Reduced |
| Geode Capital Management, LLC | 90,026 | $507.7K | 0.00% | +32,252+55.8% | Added |
| CM Management, LLC | 75,000 | $423.0K | 0.41% | +15,000+25.0% | Added |
| Redmond Asset Management, LLC | 46,604 | $262.8K | 0.09% | −2,585−5.3% | Reduced |
| Renaissance Technologies LLC | 44,900 | $253.0K | 0.00% | +20,300+82.5% | Added |
| Horizon Kinetics Asset Management LLC | 30,000 | $169.2K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 27,752 | $156.5K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 27,000 | $152.3K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 26,480 | $149.3K | 0.00% | 00.0% | Unchanged |
| Wolff Wiese Magana LLC | 25,145 | $141.8K | 0.11% | −1,333−5.0% | Reduced |
| Citadel Advisors LLC | 24,737 | $139.5K | 0.00% | +13,761+125.4% | Added |
| BlackRock Inc. | 20,799 | $117.3K | 0.00% | −651−3.0% | Reduced |
| Sigma Planning Corp | 18,125 | $102.2K | 0.00% | +850+4.9% | Added |
| Commonwealth Equity Services, LLC | 16,813 | $95.0K | 0.00% | −3,373−16.7% | Reduced |
| Pathway Financial Advisors LLC | 14,001 | $79.0K | 0.03% | +14,001 | New |
| Northern Trust Corp | 12,593 | $71.0K | 0.00% | −36−0.3% | Reduced |
| Susquehanna International Group, LLP | 10,581 | $59.7K | 0.00% | +10,581 | New |
| Wells Fargo & Company | 4,488 | $25.3K | 0.00% | +20.0% | Added |
| Tower Research Capital LLC (TRC) | 2,339 | $13.2K | 0.00% | +222+10.5% | Added |
| Rhumbline Advisers | 228 | $1.28K | 0.00% | +228 | New |
| Advisor Group Holdings, Inc. | 200 | $1.13K | 0.00% | +200 | New |
| Royal Bank of Canada | 206 | $1.00K | 0.00% | +206 | New |
| Allworth Financial LP | 100 | $564 | 0.00% | 00.0% | Unchanged |
| Cranbrook Wealth Management, LLC | 0 | $0 | 0.00% | −717−100.0% | Sold out |